Myeloproliferative neoplasm differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
Myeloproliferative neoplasm must be differentiated from [[acute lymphoblastic leukemia]], [[acute myelogenous leukemia]], [[chronic myelogenous leukemia]], [[essential thrombocytosis]], [[hypereosinophilic syndrome]], [[non-Hodgkin lymphoma]], [[primary myelofibrosis]], secondary thrombocytosis, [[splenomegaly]], [[systemic mastocytosis]], and [[waldenstrom macroglobulinemia]]. | Myeloproliferative neoplasm must be differentiated from [[acute lymphoblastic leukemia]], [[acute myelogenous leukemia]], [[chronic myelogenous leukemia]], [[essential thrombocytosis]], [[hypereosinophilic syndrome]], [[non-Hodgkin lymphoma]], [[primary myelofibrosis]], secondary thrombocytosis, [[splenomegaly]], [[systemic mastocytosis]], and [[waldenstrom macroglobulinemia]].<ref>{{Cite journal | ||
| author = [[James W. Vardiman]], [[Nancy Lee Harris]] & [[Richard D. Brunning]] | |||
| title = The World Health Organization (WHO) classification of the myeloid neoplasms | |||
| journal = [[Blood]] | |||
| volume = 100 | |||
| issue = 7 | |||
| pages = 2292–2302 | |||
| year = 2002 | |||
| month = October | |||
| doi = 10.1182/blood-2002-04-1199 | |||
| pmid = 12239137 | |||
}}</ref> | |||
<ref>{{Cite journal | |||
| author = [[A. Tefferi]], [[L. A. Solberg]] & [[M. N. Silverstein]] | |||
| title = A clinical update in polycythemia vera and essential thrombocythemia | |||
| journal = [[The American journal of medicine]] | |||
| volume = 109 | |||
| issue = 2 | |||
| pages = 141–149 | |||
| year = 2000 | |||
| month = August | |||
| pmid = 10967156 | |||
}}</ref> | |||
==Differentiating Myeloproliferative neoplasm from other Diseases== | ==Differentiating Myeloproliferative neoplasm from other Diseases== | ||
Myeloproliferative neoplasm must be differentiated from: | Myeloproliferative neoplasm must be differentiated from:<ref>{{Cite journal | ||
| author = [[James W. Vardiman]], [[Nancy Lee Harris]] & [[Richard D. Brunning]] | |||
| title = The World Health Organization (WHO) classification of the myeloid neoplasms | |||
| journal = [[Blood]] | |||
| volume = 100 | |||
| issue = 7 | |||
| pages = 2292–2302 | |||
| year = 2002 | |||
| month = October | |||
| doi = 10.1182/blood-2002-04-1199 | |||
| pmid = 12239137 | |||
}}</ref> | |||
<ref>{{Cite journal | |||
| author = [[A. Tefferi]], [[L. A. Solberg]] & [[M. N. Silverstein]] | |||
| title = A clinical update in polycythemia vera and essential thrombocythemia | |||
| journal = [[The American journal of medicine]] | |||
| volume = 109 | |||
| issue = 2 | |||
| pages = 141–149 | |||
| year = 2000 | |||
| month = August | |||
| pmid = 10967156 | |||
}}</ref> | |||
*[[Acute lymphoblastic leukemia]] | *[[Acute lymphoblastic leukemia]] | ||
*[[Acute myelogenous leukemia]] | *[[Acute myelogenous leukemia]] |
Revision as of 20:00, 27 October 2015
Myeloproliferative Neoplasm Microchapters |
Differentiating myeloproliferative neoplasm from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Myeloproliferative neoplasm differential diagnosis On the Web |
American Roentgen Ray Society Images of Myeloproliferative neoplasm differential diagnosis |
Myeloproliferative neoplasm differential diagnosis in the news |
Directions to Hospitals Treating Myeloproliferative neoplasm |
Risk calculators and risk factors for Myeloproliferative neoplasm differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Myeloproliferative neoplasm must be differentiated from acute lymphoblastic leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, essential thrombocytosis, hypereosinophilic syndrome, non-Hodgkin lymphoma, primary myelofibrosis, secondary thrombocytosis, splenomegaly, systemic mastocytosis, and waldenstrom macroglobulinemia.[1] [2]
Differentiating Myeloproliferative neoplasm from other Diseases
Myeloproliferative neoplasm must be differentiated from:[3] [4]
- Acute lymphoblastic leukemia
- Acute myelogenous leukemia
- Chronic myelogenous leukemia
- Essential thrombocytosis
- Hypereosinophilic syndrome
- Non-Hodgkin lymphoma
- Primary myelofibrosis
- Secondary thrombocytosis
- Splenomegaly
- Systemic mastocytosis
- Waldenstrom macroglobulinemia
References
- ↑ James W. Vardiman, Nancy Lee Harris & Richard D. Brunning (2002). "The World Health Organization (WHO) classification of the myeloid neoplasms". Blood. 100 (7): 2292–2302. doi:10.1182/blood-2002-04-1199. PMID 12239137. Unknown parameter
|month=
ignored (help) - ↑ A. Tefferi, L. A. Solberg & M. N. Silverstein (2000). "A clinical update in polycythemia vera and essential thrombocythemia". The American journal of medicine. 109 (2): 141–149. PMID 10967156. Unknown parameter
|month=
ignored (help) - ↑ James W. Vardiman, Nancy Lee Harris & Richard D. Brunning (2002). "The World Health Organization (WHO) classification of the myeloid neoplasms". Blood. 100 (7): 2292–2302. doi:10.1182/blood-2002-04-1199. PMID 12239137. Unknown parameter
|month=
ignored (help) - ↑ A. Tefferi, L. A. Solberg & M. N. Silverstein (2000). "A clinical update in polycythemia vera and essential thrombocythemia". The American journal of medicine. 109 (2): 141–149. PMID 10967156. Unknown parameter
|month=
ignored (help)